BioRestorative Therapies, Inc. (BRTX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 3.8M | 3.14M | 4.7M | 7.6M | 9.36M | 11.14M | 13.51M | 15M | 16.77M | 11.39M | 12.6M | 12.04M |
| Cash & Short-Term Investments | 3.59M | 2.95M | 4.49M | 7.38M | 9.11M | 10.73M | 13.09M | 14.68M | 16.42M | 11.07M | 12.24M | 11.62M |
| Cash Only | 3.11M | 1.51M | 602.44K | 1.56M | 1.23M | 547.89K | 1.49M | 2.25M | 1.16M | 884.38K | 2.44M | 1.78M |
| Short-Term Investments | 479.35K | 1.44M | 3.89M | 5.83M | 7.88M | 10.18M | 11.6M | 12.43M | 15.26M | 10.18M | 9.8M | 9.83M |
| Accounts Receivable | 13.3K | 15.5K | 13.4K | 15K | 25K | 188.4K | 165K | 27.4K | 35K | 19.3K | 39.3K | 25K |
| Days Sales Outstanding | 55.93 | 67.83 | 110.71 | 6 | 384.12 | 375.44 | 37.89 | 31.87 | 70.59 | 139.67 | 96.35 | 28.92 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 194.38K | 168.44K | 196.75K | 201.87K | 217.4K | 223.23K | 256.08K | 0 | 1 | 0 | 0 | 403.56K |
| Total Non-Current Assets | 840.57K | 942.77K | 942.69K | 918.75K | 971.5K | 1.14M | 1.06M | 1.12M | 1.18M | 1.22M | 1.2M | 1.26M |
| Property, Plant & Equipment | 328.81K | 358.77K | 309.5K | 339.68K | 369.99K | 362.94K | 418.13K | 423.95K | 480.41K | 507.5K | 461.04K | 497.81K |
| Fixed Asset Turnover | 0.07x | 0.06x | 0.04x | 0.85x | 0.07x | 0.11x | 0.55x | 0.20x | 0.07x | 0.04x | 0.06x | 0.13x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 511.76K | 534.2K | 556.63K | 579.07K | 601.51K | 623.95K | 646.38K | 668.82K | 691.25K | 713.69K | 736.13K | 758.57K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 49.81K | 76.56K | 0 | 0 | 148.7K | 0 | 22.38K | 9.54K | 0 | 0 | 0 |
| Total Assets | 4.64M | 4.08M | 5.64M | 8.52M | 10.33M | 12.28M | 14.57M | 16.12M | 17.95M | 12.61M | 13.8M | 13.3M |
| Asset Turnover | 0.01x | 0.00x | 0.00x | 0.03x | 0.00x | 0.00x | 0.02x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x |
| Asset Growth % | -55.07% | -66.78% | -61.28% | -47.16% | -42.47% | -2.63% | 5.6% | 21.19% | 27.49% | -23.26% | -22.99% | -31.59% |
| Total Current Liabilities | 1.61M | 3.72M | 3.44M | 3.67M | 4.18M | 3.75M | 4.58M | 5.32M | 3.45M | 2.61M | 932.62K | 812.85K |
| Accounts Payable | 666.9K | 1.34M | 859.9K | 609.93K | 599.5K | 483.07K | 401.38K | 215.92K | 230.9K | 189.39K | 227.35K | 276.05K |
| Days Payables Outstanding | 12.24K | 61.9K | 6.4K | 6.3K | 16.75K | 12.18K | 1.56K | 3.13K | - | 448.81 | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 162.32K | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 150K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 947.74K | 2.38M | 2.04M | 2.7M | 3.15M | 2.52M | 3.55M | 4.57M | 2.76M | 2.26M | 0 | 0 |
| Current Ratio | 2.35x | 0.84x | 1.37x | 2.07x | 2.24x | 2.97x | 2.95x | 2.82x | 4.86x | 4.37x | 13.51x | 14.82x |
| Quick Ratio | 2.35x | 0.84x | 1.37x | 2.07x | 2.24x | 2.97x | 2.95x | 2.82x | 4.86x | 4.37x | 13.51x | 14.82x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 42.41K | 83.58K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42.41K | 83.58K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 |
| Total Liabilities | 1.61M | 3.72M | 3.44M | 3.67M | 4.18M | 3.75M | 4.58M | 5.32M | 3.45M | 2.61M | 975.03K | 896.43K |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 42.41K | 83.58K | 123.54K | 162.32K | 198.72K | 234.06K |
| Net Debt | -3.11M | -1.51M | -602.44K | -1.56M | -1.23M | -547.89K | -1.45M | -2.17M | -1.03M | -722.06K | -2.24M | -1.55M |
| Debt / Equity | - | - | - | - | - | - | 0.00x | 0.01x | 0.01x | 0.02x | 0.02x | 0.02x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | -18.29x | - | - |
| Total Equity | 3.03M | 356.74K | 2.21M | 4.85M | 6.14M | 8.53M | 9.99M | 10.8M | 14.5M | 10M | 12.83M | 12.4M |
| Equity Growth % | -50.76% | -95.82% | -77.91% | -55.13% | -57.63% | -14.72% | -22.1% | -12.94% | 7.54% | -2.78% | -24.57% | -33.26% |
| Book Value per Share | 0.34 | 0.04 | 0.24 | 0.55 | 0.74 | 1.10 | 1.23 | 1.33 | 2.17 | 2.13 | 2.81 | 3.19 |
| Total Shareholders' Equity | 3.03M | 356.74K | 2.21M | 4.85M | 6.14M | 8.53M | 9.99M | 10.8M | 14.5M | 10M | 12.83M | 12.4M |
| Common Stock | 2.55K | 887 | 797 | 797 | 750 | 692 | 692 | 692 | 677 | 471 | 468 | 399 |
| Retained Earnings | -172.08M | -169.92M | -166.71M | -163.67M | -161.02M | -155.68M | -154.04M | -152.95M | -148.92M | -146.7M | -164.23M | -161.31M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |